Sort
16,300 grants matching “fatty liver disease”
Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells
$314,935Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2022 · CA
Role of n3 PUFAs and inflammation-resolving lipid mediator, RvD1, in alcoholic liver disease
$314,864Irina A. Kirpich · University Of Louisville · P50 · FY2023 · AA
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
$314,815Phillip B Hylemon · Virginia Commonwealth University · R01 · FY2007 · AI
Multi-Tissue MAFLD Chip for Mechanism-Based Drug Testing
$314,803Murat Cirit · Javelin Biotech · R43 · FY2022 · TR
Project 1 - Cardiometabolic Injury due to VOCs
$314,767Aruni Bhatnagar Bhatnagar · University Of Louisville · P42 · FY2024 · ES
Exercise & Pioglitazone for HIV-Metabolic Syndromes
$314,736Kevin E Yarasheski · Washington University · R01 · FY2007 · DK
Bariatric Surgery Research Consortium
$314,649University Of Washington · U01 · FY2003 · DK
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
$314,573Kusum K. Kharbanda · University Of Nebraska Medical Center · R01 · FY2021 · AA
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
$314,573Kusum K. Kharbanda · University Of Nebraska Medical Center · R01 · FY2019 · AA
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
$314,573Kusum K. Kharbanda · University Of Nebraska Medical Center · R01 · FY2022 · AA
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
$314,573Kusum K. Kharbanda · University Of Nebraska Medical Center · R01 · FY2020 · AA
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
$314,573Kusum K. Kharbanda · University Of Nebraska Medical Center · R01 · FY2018 · AA
Tumor -Targeting Chemotherapeutic Agents
$314,565Iwao Ojima · State University New York Stony Brook · R01 · FY2011 · CA
Tumor -Targeting Chemotherapeutic Agents
$314,565Iwao Ojima · State University New York Stony Brook · R01 · FY2012 · CA
NASH Clinical Research Network
$314,528Anna Mae Elizabeth Diehl · Duke University · U01 · FY2009 · DK
Adipose Tissue Lipolysis and Alcoholic Fatty Liver
$314,500Zhanxiang Zhou · University Of Louisville · R01 · FY2009 · AA
Hepatic expression of small hairpin RNA using gutless adenoviral vectors
$314,489Nuria Morral · Indiana University Indianapolis · R01 · FY2011 · DK
Hepatic expression of small hairpin RNA using gutless adenoviral vectors
$314,489Nuria Morral · Indiana University Indianapolis · R01 · FY2012 · DK
Heptax for Alcoholic Liver Disease
$314,438Fredric J. Pashkow · Cardax Pharmaceuticals, Inc. · R44 · FY2009 · AA
Omics Core
$314,411Xiang Zhang · University Of Louisville · P20 · FY2022 · GM
Investigation of Novel IgY Technology for Fungal Targets in Alcohol-associated Hepatitis
$314,363Satishchandran Chandrasekhar · Prodigy Biotech, Inc. · R41 · FY2025 · AI
Omega-3 Fatty Acids and Hepatic Carcinogenesis
$314,363Tong Wu · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
Metabolic regulation of adipocyte-macrophage crosstalk in obesity
$314,306Chaodong Wu · Texas A&M Agrilife Research · R01 · FY2015 · DK
Metabolic regulation of adipocyte-macrophage crosstalk in obesity
$314,306Chaodong Wu · Texas A&M Agrilife Research · R01 · FY2014 · DK
Metabolic regulation of adipocyte-macrophage crosstalk in obesity
$314,306Chaodong Wu · Texas A&M Agrilife Research · R01 · FY2016 · DK